<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>380-NIFEDIPINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="NIFEDIPINE" rxcui="7417">
<ATC code="C08CA05" />
<ATC code="C08GA01" />
<ATC code="C08CA55" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="CICLOSPORIN" rxcui="3008">
<ATC code="L04AD01" />
<ATC code="S01XA18" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of addition of undesirable effects of the gum disorders type</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
<COMMENT>Use another dihydropyridine</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>380-NIFEDIPINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="NIFEDIPINE" rxcui="7417">
<ATC code="C08CA05" />
<ATC code="C08GA01" />
<ATC code="C08CA55" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="CIMETIDINE" rxcui="2541">
<ATC code="A02BA01" />
<ATC code="A02BA51" />
</DRUG>
</DRUG2>
<DESCRIPTION>With the cimetidine used in doses greater than or equal to 800 mg/day: increase of the hypotensive effect of the nifedipine due to inhibition of its hepatic metabolism by the cimetidine</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Increased clinical monitoring: adjust the dosage of the nifedipine during the treatment with the cimetidine and after it is stopped. </COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>380-NIFEDIPINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="NIFEDIPINE" rxcui="7417">
<ATC code="C08CA05" />
<ATC code="C08GA01" />
<ATC code="C08CA55" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="DILTIAZEM" rxcui="3443">
<ATC code="C08DB01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Large increase of the concentrations of nefedipine due to decrease of its hepatic metabolism by the diltiazem, with risk of severe hypotension</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
</INTERACTIONS>
